NSE - Delayed Quote INR

Thyrocare Technologies Limited (THYROCARE.NS)

655.00 -4.80 (-0.73%)
At close: 3:30 PM GMT+5:30

Key Executives

Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in INR.
NameTitlePayExercisedYear Born
Mr. Rahul Franklin Guha MD, CEO & Chairman -- -- 1978
Mr. K. KallathiKumar Chief Operating Officer -- -- --
Mr. Ramjee Dorai Company Secretary & Compliance Officer -- -- 1947
Mr. Aditya Shinde Vice President -- -- 1988
Mr. Alok Kumar Jagnani Chief Financial Officer -- -- --
Mr. Pratik Hire Head of Strategy & Investor Relations -- -- --
Mr. Nitin Chugh Chief Commercial Officer -- -- --

Thyrocare Technologies Limited

D/37-3, TTC Industrial Area
MIDC, Turbhe
Navi Mumbai, 400703
India
91 22 4125 2525 https://www.thyrocare.com
Sector: 
Healthcare
Full Time Employees: 
1,645

Description

Thyrocare Technologies Limited provides diagnostic testing services to patients, laboratories, and hospitals in India. It operates in three segments: Diagnostic Testing Services, Imaging Services, and Others. The company conducts various medical diagnostic tests and profiles of tests that focuses on early detection and management of disorders and diseases, including thyroid, growth, metabolism, auto-immunity, diabetes, anaemia, cardiovascular, infertility, COVID, and various infectious diseases. Its profiles of tests include profiles of tests administered under its Aarogyam brand, which offers patients a suite of wellness and preventive health care tests. The company sells glucometer and glucostrips under the brand name Sugarscan; consumables; and radiopharmaceutical. Thyrocare Technologies Limited was founded in 1996 and is based in Navi Mumbai, India. Thyrocare Technologies Limited is a subsidiary of Docon Technologies Private Limited.

Corporate Governance

Thyrocare Technologies Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Recent Events

  • Apr 20, 2023
    Ex-Dividend Date

Upcoming Events

May 21, 2024 - May 25, 2024
Thyrocare Technologies Limited Earnings Call

Related Tickers